Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of SkQ1 as Treatment for Dry-eye Syndrome

ClinicalTrials.gov ID: NCT03764735

Public ClinicalTrials.gov record NCT03764735. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 1:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of SkQ1 Ophthalmic Solution for the Treatment of Dry Eye Syndrome

Study identification

NCT ID
NCT03764735
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Mitotech, SA
Industry
Enrollment
452 participants

Conditions and interventions

Interventions

  • Low Dose - SkQ1 Drug
  • High dose - SkQ1 Drug
  • SkQ1 (Vehicle) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 5, 2018
Primary completion
Feb 8, 2019
Completion
Feb 8, 2019
Last update posted
Jan 18, 2022

2018 – 2019

United States locations

U.S. sites
7
U.S. states
7
U.S. cities
7
Facility City State ZIP Site status
Cornea & Cataract Consultants of Arizona Phoenix Arizona 85032
Eye Research Foundation Newport Beach California 92663
Eye Care Insititute Louisville Kentucky 40206
Central Maine Eye Care Lewiston Maine 04240
Andover Eye Associates Andover Massachusetts 01810
Vita Eye Clinic Shelby North Carolina 28150
Total Eye Care, PA Memphis Tennessee 38119

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03764735, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 18, 2022 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03764735 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →